{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:01:58Z","timestamp":1774465318842,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.taap.2024.117143","type":"journal-article","created":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T15:02:23Z","timestamp":1730646143000},"page":"117143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Valifenalate-induced non-adverse thyroid changes via adaptive induction of uridine 5\u2032-diphospho-glucuronosyltransferase (UGT) in the liver of dogs and rats but not humans"],"prefix":"10.1016","volume":"494","author":[{"given":"Christine","family":"Walter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Baze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lysiane","family":"Richert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Bomann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.taap.2024.117143_bb0005","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0041-008X(83)90233-8","article-title":"Reversibility of ethylenethiourea-induced thyroid lesions","volume":"67","author":"Arnold","year":"1983","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2024.117143_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2023.105763","article-title":"Comparison of in vitro thyroxine (T4) metabolism between Wistar rat and human hepatocyte cultures","volume":"96","author":"Baze","year":"2024","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.taap.2024.117143_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.104884","article-title":"Metribuzin-induced non-adverse liver changes result in rodent-specific non-adverse thyroid effects via uridine 5\u2032-diphospho-glucuronosyltransferase (UDPGT, UGT) modulation","volume":"122","author":"Bomann","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"3 Suppl","key":"10.1016\/j.taap.2024.117143_bb0020","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1293\/tox.31.1S","article-title":"Nonproliferative and proliferative lesions of the rat and mouse endocrine system","volume":"31","author":"Br\u00e4ndli-Baiocco","year":"2018","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.taap.2024.117143_bb0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/019262339702500109","article-title":"Mechanistic data and risk assessment of selected toxic end points of the thyroid","volume":"25","author":"Capen","year":"1997","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2024.117143_bb0030","series-title":"Endocrine and Hormonal Toxicology","first-page":"33","article-title":"Thyroid and parathyroid toxicology","author":"Capen","year":"1999"},{"key":"10.1016\/j.taap.2024.117143_bb0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/taap.2000.9019","article-title":"Dietary genistein inactivates rat thyroid peroxidase in vivo without an apparent hypothyroid effect","volume":"168","author":"Chang","year":"2000","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"10.1016\/j.taap.2024.117143_bb0040","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/bdrb.10045","article-title":"Role of thyroid hormones in human and laboratory animal reproductive health","volume":"68","author":"Choksi","year":"2003","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.taap.2024.117143_bb0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.yrtph.2016.12.004","article-title":"Approaches for grouping of pesticides into cumulative assessment groups for risk assessment of pesticide residues in food","volume":"83","author":"Colnot","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2024.117143_bb0050","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/10408440600975242","article-title":"Thiazopyr and thyroid disruption: case study within the context of the 2006 IPCS human relevance framework for analysis of a cancer mode of action","volume":"36","author":"Dellarco","year":"2006","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2024.117143_bb0055","article-title":"Guidance for the identification of endocrine disruptors in the context of regulations (EU) no 528\/2012 and (EC) no 1107\/2009","volume":"16","author":"ECHA and EFSA","year":"2018","journal-title":"EFSA J."},{"key":"10.1016\/j.taap.2024.117143_bb0060","author":"ECHA\/RAC","year":"2020"},{"issue":"9","key":"10.1016\/j.taap.2024.117143_bb0065","first-page":"5801","article-title":"Establishment of cumulative assessment groups of pesticides for their effects on the thyroid","volume":"17","author":"EFSA","year":"2019","journal-title":"EFSA J."},{"key":"10.1016\/j.taap.2024.117143_bb0070","series-title":"Guideline on the Investigation of Drug Interactions, CPMP\/EWP\/560\/95\/Rev. 1 Corr. 2**, Committee for Human Medicinal Products (CHMP)","author":"EMA","year":"2012"},{"key":"10.1016\/j.taap.2024.117143_bb0075","author":"EURL ECVAM","year":"2012"},{"key":"10.1016\/j.taap.2024.117143_bb0080","first-page":"1","article-title":"Regulation (EC) no 1107\/2009 of the European Parliament and of the council of 21 October 2009 concerning the placing of plant protection products on the market and repealing council directives 79\/117\/EEC and 91\/414\/EEC","author":"European Commission","year":"2009","journal-title":"Off. J. Eur. Union"},{"key":"10.1016\/j.taap.2024.117143_bb0085","series-title":"Commission Regulation (EU) No 283\/2013 of 1 March 2013 Setting Out the Data Requirements for Active Substances, in Accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council. OJ L 93","first-page":"1","author":"European Commission","year":"2013"},{"key":"10.1016\/j.taap.2024.117143_bb0090","series-title":"US Food and Drug Administration. Guidance for Industry: In Vitro Drug Interaction Studies - Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions","author":"FDA","year":"2020"},{"issue":"14","key":"10.1016\/j.taap.2024.117143_bb0095","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1939-1676.2000.tb01167.x","article-title":"Thyroid function and serum hepatic enzyme activity in dogs after phenobarbital administration","author":"Gieger","year":"2000","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.taap.2024.117143_bb0100","series-title":"Hayes\u2019 Principles and Methods of Toxicology","author":"Hayes","year":"2014"},{"key":"10.1016\/j.taap.2024.117143_bb0105","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1289\/ehp.98106447","article-title":"Risk assessment of thyroid follicular cell tumors","volume":"106","author":"Hill","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2024.117143_bb0110","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1177\/0192623313503516","article-title":"Effects of lersivirine on canine and rodent thyroid function","volume":"42","author":"Houle","year":"2013","journal-title":"Toxicol. Pathol."},{"issue":"8","key":"10.1016\/j.taap.2024.117143_bb0115","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1177\/0192623320972009","article-title":"Adversity considerations for thyroid follicular cell hypertrophy and hyperplasia in nonclinical toxicity studies: results from the 6th ESTP international expert workshop","volume":"48","author":"Huisinga","year":"2020","journal-title":"Toxicol. Pathol."},{"issue":"8","key":"10.1016\/j.taap.2024.117143_bb0120","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1289\/ehp.98106437","article-title":"Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents","volume":"106","author":"Hurley","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2024.117143_bb0125","series-title":"Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis","volume":"147","author":"IARC","year":"1999"},{"key":"10.1016\/j.taap.2024.117143_bb0130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1289\/ehp.6637","article-title":"Thyroid toxicants: assessing reproductive health effects","volume":"112","author":"Jahnke","year":"2004","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2024.117143_bb0135","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2460\/javma.2001.219.765","article-title":"Serum total thyroxine, total triiodothyronine, free thyroxine, and thyrotropin concentrations in dogs with nonthyroidal disease","volume":"219","author":"Kantrowitz","year":"2001","journal-title":"JAVMA"},{"key":"10.1016\/j.taap.2024.117143_bb0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0027-5107(95)00139-5","article-title":"Mechanistic considerations for the relevance of animal data on thyroid neoplasia to human risk assessment","volume":"333","author":"McClain","year":"1995","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2024.117143_bb0145","series-title":"Draft Performance Standards for New Human Cytochrome P450 (CYP) n-Fold Induction in vitro Test Method for TG xxx","author":"OECD","year":"2014"},{"key":"10.1016\/j.taap.2024.117143_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115831","article-title":"Evaluation of human relevance of nicofluprole-induced rat thyroid disruption","volume":"435","author":"Parmentier","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2024.117143_bb0155","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.tox.2013.08.006","article-title":"Cross-species analysis of thyroperoxidase inhibition by xenobiotics demonstrates conservation of response between pig and rat","volume":"312","author":"Paul","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2024.117143_bb0160","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1021\/tx400310w","article-title":"Development of a thyroperoxidase inhibition assay for high-throughput screening","volume":"27","author":"Paul","year":"2014","journal-title":"Chem. Res. Toxicol."},{"issue":"5","key":"10.1016\/j.taap.2024.117143_bb0165","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/00498254.2013.847990","article-title":"In vitro metabolism of thyroxine by rat and human hepatocytes","volume":"44","author":"Richardson","year":"2014","journal-title":"Xenobiotica"},{"issue":"9","key":"10.1016\/j.taap.2024.117143_bb0170","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1080\/10408444.2020.1839380","article-title":"Toward a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny \u2013 part I: which parameters from human studies are most relevant for toxicological assessments?","volume":"50","author":"Sauer","year":"2020","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2024.117143_bb0175","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1124\/mol.54.6.1113","article-title":"Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element","volume":"54","author":"Schuetz","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2024.117143_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2022.964553","article-title":"Use of new approach methodologies (NAMs) to meet regulatory requirements for the assessment of industrial chemicals and pesticides for effects on human health","volume":"4","author":"Stucki","year":"2022","journal-title":"Front. Toxicol."},{"issue":"2","key":"10.1016\/j.taap.2024.117143_bb0185","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/030098588602300202","article-title":"Induction and reversibility of thyroid proliferative changes in rats given an antithyroid compound","volume":"23","author":"Todd","year":"1986","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.taap.2024.117143_bb0190","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ab.2009.08.038","article-title":"A nonradioactive iodide uptake assay for sodium iodide symporter function","volume":"396","author":"Waltz","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.taap.2024.117143_bb0195","series-title":"International Programme on Chemical Safety - Global Assessment of the State-of-the-Science of Endocrine Disruptors","author":"WHO\/IPCS","year":"2002"},{"key":"10.1016\/j.taap.2024.117143_bb0200","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/jat.4427","article-title":"Boscalid shows increased thyroxin-glucuronidation in rat but not in human hepatocytes in vitro","volume":"43","author":"Wiemann","year":"2023","journal-title":"J. Appl. Toxicol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24003429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24003429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T09:52:35Z","timestamp":1733997155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X24003429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":40,"alternative-id":["S0041008X24003429"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2024.117143","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valifenalate-induced non-adverse thyroid changes via adaptive induction of uridine 5\u2032-diphospho-glucuronosyltransferase (UGT) in the liver of dogs and rats but not humans","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2024.117143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117143"}}